|
Zileuton as a chemopreventive agent for chronic myeloid leukemia
|
5R01CA176179-05
|
$347,563
|
|
LI, SHAOGUANG
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Yoga Versus CBT-I for Insomnia in Cancer Survivors and Biobehavioral Mechanisms
|
5R01CA181064-05
|
$593,588
|
|
MUSTIAN, KAREN
|
UNIVERSITY OF ROCHESTER
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-10
|
$2,574,000
|
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Virus-Targeted Therapy for Malignancies
|
1R43CA153474-01A1
|
$288,895
|
$144,448
|
PERRINE, SUSAN
|
PHOENICIA BIOSCIENCES, INC.
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Out
|
ZIA CP010126-00580
|
$48,591
|
$2,429
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
VEGF signaling in Mammary Tumorigenesis
|
5R01CA168464-07
|
$397,813
|
|
MERCURIO, ARTHUR
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
VCU Massey Cancer Center Support Grant
|
5P30CA016059-37
|
$2,170,000
|
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Validation of a disposable biospecimen collection system with integral refrigeration for preserving the phosphoproteome
|
1R21CA225507-01
|
$280,976
|
|
PAULOVICH, AMANDA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S1
|
$74,970
|
$750
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S2
|
$139,926
|
$1,399
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-38
|
$4,555,705
|
$45,557
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$91,803
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UT M.D. Anderson Cancer Center Lymphoma SPORE
|
5P50CA136411-03
|
$475,000
|
$109,250
|
YOUNES, ANAS
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Using 18F-EF5 PET to measure hypoxia modulation by Nelfinavir in larynx cancer
|
5R01CA174976-05
|
$351,104
|
|
MAITY, AMIT
|
UNIVERSITY OF PENNSYLVANIA
|
|
University of Rochester Cancer Center CCOP Research Base
|
5U10CA037420-27
|
$2,137,632
|
$21,376
|
Morrow, Gary
|
UNIVERSITY OF ROCHESTER
|
|
University of Pittsburgh Multicenter AIDS Cohort Study (MACS)
|
5U01AI035041-26
|
$210,000
|
|
RINALDO, CHARLES
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
University of Colorado Southwest Oncology Group
|
5U10CA042777-24
|
|
$0
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding Wnt5a regulation of protein depalmitoylation during cell migration
|
5R01CA181633-05
|
$332,000
|
|
WITZE, ERIC
|
UNIVERSITY OF PENNSYLVANIA
|
|
Understanding the Determinants of Racial/Ethnic Disparities in Liver Cancer and Chronic Liver Disease in Understudied and High-Risk Populations
|
1R01CA228589-01
|
$601,819
|
|
SETIAWAN, VERONICA
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$218,895
|
$21,889
|
Fowler, Daniel
|
CCR (NCI)
|
|
UCLA Tumor Immunology Institutional Traning Grant
|
2T32CA009120-41A1
|
$497,990
|
|
TEITELL, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
UAB Center for AIDS Research
|
5P30AI027767-30
|
$162,000
|
|
SAAG, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
UAB Cancer Prevention and Control Training Program (T32)
|
2T32CA047888-29
|
$288,255
|
|
DEMARK-WAHNEFRIED, WENDY
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
U10 Full Member Application Affiliated with SWOG
|
5U10CA105409-08
|
$325,684
|
$3,257
|
Kim, Edward
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Tumor-Targeted Chemo-Immunotherapy for Osteosarcoma Metastasis
|
5R01CA200574-03
|
$359,138
|
|
ZHANG, LIANGFANG
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Tumor-Infiltrating Donor Derived Lymphocyte Therapy After Allogeneic Transplant
|
ZIC BC 011029
|
$183,451
|
$73,380
|
Hakim, Frances
|
CCR (NCI)
|
|
Tumor vasculature-targeted nanotherapeutics for DNA damage response
|
5R01CA193880-03
|
$364,856
|
|
SHEN, HAIFA
|
METHODIST HOSPITAL RESEARCH INSTITUTE
|
|
TSPO-PET to Image Pancreatic Cancer and High-Risk Precursor Lesions
|
5F30CA196087-03
|
$49,524
|
|
WATCHMAKER, JENNIFER
|
VANDERBILT UNIVERSITY
|
|
Treating cognitive impairments in cancer patients via systematic light exposure
|
5K07CA184145-05
|
$166,167
|
|
WU, LISA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Translational Research in Cancer
|
2P30CA056036-19
|
$2,888,240
|
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Genomics and Precision Medicine in Cancer Training Program
|
1T32CA217789-01A1
|
$236,106
|
|
KILLARY, ANN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Training Program in Skin Biology and Cancer
|
5T32CA175294-05
|
$28,920
|
|
KIRKWOOD, JOHN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Training in Pediatric Cancer Survivorship Outcomes and Interventions
|
1T32CA225590-01
|
$244,999
|
|
KRULL, KEVIN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Training Grant in Tumor Biology
|
5T32CA009686-22
|
$598,069
|
|
RIEGEL, ANNA
|
GEORGETOWN UNIVERSITY
|
|
Towards selective androgen deprivation by targeting androgen activation of SRF
|
5R01CA166440-05
|
$338,994
|
|
HEEMERS, HANNELORE
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Towards a Mouse Model of Classical Hodgkin's Disease and PTLD
|
5R01CA098285-08
|
$490,125
|
$490,125
|
ALT, FREDERICK
|
IMMUNE DISEASE INSTITUTE, INC.
|
|
To establish the BC Cancer Agency - Vancouver Centre as a major SWOG centre
|
5U10CA142559-02
|
$188,304
|
$1,883
|
BLANKE, CHARLES
|
BRITISH COLUMBIA CANCER AGENCY
|
|
To enhance breast cancer survivorship of Asian Americans
|
5R01CA203719-03
|
$576,193
|
|
IM, EUN-OK
|
DUKE UNIVERSITY
|
|
Tissue Specific Regulation of Diabetes-Associated Cancer Growth
|
5R01CA177771-05
|
$328,888
|
|
STENINA, OLGA
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Therapeutic and Sustained Cytokine Delivery at the Tumor Site Using Engineered Mononuclear Cells
|
5F30CA203325-03
|
$38,249
|
|
DONAHUE, PATRICK
|
NORTHWESTERN UNIVERSITY
|
|
The Yap-Tead transcriptional complex in Kras-induced Pancreatic Ductal Adenocarci
|
5R01CA187090-05
|
$322,663
|
|
YI, CHUNLING
|
GEORGETOWN UNIVERSITY
|
|
The Tumor Suppressor Role of SMARCA4 in SCCOHT
|
5R01CA195670-04
|
$714,783
|
|
WEISSMAN, BERNARD
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
The Tumor Suppressor Function of Dnmt3a in Chronic Lymphocytic Leukemia
|
5R01CA188561-05
|
$348,844
|
|
OPAVSKY, RENE
|
UNIVERSITY OF FLORIDA
|
|
The tumor suppressive role of PBRM1, the bromodomain-containing subunit of the PBAF chromatin remodeling complex
|
5U01CA207532-02
|
$349,332
|
|
DYKHUIZEN, EMILY
|
PURDUE UNIVERSITY
|
|
The role of short-form Ron (sfRon) kinase in the pathogenesis of high-grade serous ovarian cancer
|
5K22CA207602-02
|
$159,705
|
|
BIENIASZ, MAGDALENA
|
OKLAHOMA MEDICAL RESEARCH FOUNDATION
|
|
The role of MCM8-9 in genomic instability of cancers
|
5R01CA060499-24
|
$355,500
|
|
DUTTA, ANINDYA
|
UNIVERSITY OF VIRGINIA
|
|
The role of HIF2alpha in colon carcinogenesis
|
5R01CA148828-09
|
$368,125
|
|
SHAH, YATRIK
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
The role of glioblastoma derived activated leukocyte cell adhesion molecule in peripheral monocyte PD-L1 induction and immunosuppression
|
5F30CA206413-03
|
$49,524
|
|
LAMANO, JONATHAN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Role of Fbxw7 in genetic instability and cancer
|
5R01CA116481-05
|
$345,303
|
$69,061
|
Mao, Jian-Hua
|
UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
|
|
The role of ENF loss, TLR4 and spinal plasticity in paclitaxel CIPN
|
5R01CA200263-03
|
$479,883
|
|
DOUGHERTY, PATRICK
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
Total relevant funding to Hodgkins disease for this search: $14,562,075
|